Alba Therapeutics (Larazotide Acetate Assets)

Business Data, Corporate Office and Headquarter Address

About

Alba Therapeutics (Larazotide Acetate Assets) is Buildings and Property in United States that focus on junction modulator business. They cover business area such as portfolio, asset, a drug ingredient, celiac disease, acetate.

Business Type

Buildings and Property

Country

United States

Founded

-

Company Focus

Junction Modulator

Website

-

Corporate Office and Headquarter Office address:

100 International Drive 23rd Floor
Suite 1040
Baltimore, MD 21202
United States

Phone number:

Private

Office Opening Hours*:

Monday 9.30 - 17.00
Tuesday 9.30 - 17.00
Wednesday 9.30 - 17.00
Thursday 9.30 - 17.00
Friday 9.30 - 17.00
Saturday Closed
Sunday Closed

Business Coverage

portfolioasseta drug ingredientceliac diseaseacetate

* We use standard office opening hours in near Alba Therapeutics (Larazotide Acetate Assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.

Alba Therapeutics (Larazotide Acetate Assets) Frequently Asked Questions

What or who is Alba Therapeutics (Larazotide Acetate Assets)?

Alba Therapeutics (Larazotide Acetate Assets) is Buildings and Property business from United States that founded in - ( years old in ), Alba Therapeutics (Larazotide Acetate Assets) business is focusing on Junction Modulator.

Where is Alba Therapeutics (Larazotide Acetate Assets) headquarter and corporate office address?

Alba Therapeutics (Larazotide Acetate Assets) headquarter office and corporate office address is located in 100 International Drive 23rd Floor Suite 1040 Baltimore, MD 21202 United States.

Where is Alba Therapeutics (Larazotide Acetate Assets) country origins?

Alba Therapeutics (Larazotide Acetate Assets) was founded in United States.

What is Junction Modulator business focus on?

In , Alba Therapeutics (Larazotide Acetate Assets) is currently focus on junction modulator sector.

Disclaimer: This website is not affiliated with Alba Therapeutics (Larazotide Acetate Assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.